Endocrinology research centre statement about COVID-19 vaccination of diabetes mellitus patients
.
Guardado en:
Autores principales: | I. I. Dedov, M. V. Shestakova, A. Yu. Mayorov, T. V. Nikonova, G. R. Galstyan, M. Sh. Shamkhalova, O. K. Vikulova, V. Yu. Kalashnikov, N. G. Mokrysheva |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3764346bf4cf47a88b094aff76079ded |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacoeconomic assessment of type 2 diabetes mellitus care on the base of Endocrinology Research Centre, Moscow
por: Ivan Ivanovich Dedov, et al.
Publicado: (2012) -
Course and treatment of diabetes mellitus in the context of COVID-19
por: Marina V. Shestakova, et al.
Publicado: (2020) -
Consensus position of endocrinologists and pathologists on coding causes of death in patients with diabetes mellitus (expert opinion)
por: I. I. Dedov, et al.
Publicado: (2021) -
Russian association of endocrinologist draft recommendation on insulin biosimilars using
por: I. I. Dedov, et al.
Publicado: (2021) -
Pharmacogenetics of statin therapy and the endothelial function parameters in patients with type 2 diabetes mellitus
por: Nadezhda O. Lebedeva, et al.
Publicado: (2016)